From: The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada
MCID reported
Disease specific n (%)
Generic n (%)
Total n (%)
No MCID
32 (55)
33 (80)
65 (66)
MCID
26 (45)
8 (20)
34 (34)
Total
58
41
99 (p = 0.009)